These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26831096)

  • 21. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.
    Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T
    J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
    Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E
    J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus vulgaris is characterized by low IgG reactivities to specific self-antigens along with high IgG reactivity to desmoglein 3.
    Fattal I; Rimer J; Shental N; Molad Y; Gabrielli A; Livneh A; Sarig O; Goldberg I; Gafter U; Domany E; Cohen IR
    Immunology; 2014 Nov; 143(3):374-80. PubMed ID: 24820664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of autoantibodies other than anti-desmoglein in pemphigus patients.
    Mejri K; Abida O; Kallel-Sellami M; Haddouk S; Laadhar L; Zarraa IR; Ben Ayed M; Zitouni M; Mokni M; Lahmar H; Fezaa B; Turki H; Tron F; Masmoudi H; Makni S
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):774-81. PubMed ID: 21029209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
    Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
    Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting pemphigus autoantibodies through their heavy-chain variable region genes.
    Payne AS; Siegel DL; Stanley JR
    J Invest Dermatol; 2007 Jul; 127(7):1681-91. PubMed ID: 17392832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
    Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
    J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemphigus vulgaris immunoglobulin G can recognize a 130 000 MW antigen other than desmoglein 3 on peripheral blood mononuclear cell surface.
    Cirillo N; Gombos F; Lanza A
    Immunology; 2007 Jul; 121(3):377-82. PubMed ID: 17386081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody Signaling in Pemphigus Vulgaris: Development of an Integrated Model.
    Sajda T; Sinha AA
    Front Immunol; 2018; 9():692. PubMed ID: 29755451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris.
    Dhandha MM; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2012 Nov; 45(7):516-26. PubMed ID: 22779708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New targets of pemphigus vulgaris antibodies identified by protein array technology.
    Kalantari-Dehaghi M; Molina DM; Farhadieh M; Morrow WJ; Liang X; Felgner PL; Grando SA
    Exp Dermatol; 2011 Feb; 20(2):154-6. PubMed ID: 21255096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris.
    Ishii K; Harada R; Matsuo I; Shirakata Y; Hashimoto K; Amagai M
    J Invest Dermatol; 2005 May; 124(5):939-46. PubMed ID: 15854034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenic role of autoantibodies in pemphigus vulgaris.
    Pan M; Liu X; Zheng J
    Clin Exp Dermatol; 2011 Oct; 36(7):703-7. PubMed ID: 21906124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from Tunisia.
    Abida O; Kallel-Sellami M; Joly P; Ben Ayed M; Zitouni M; Masmoudi A; Mokni M; Fezzaa B; Ben Osman A; Kammoun MR; Gilbert D; Turki H; Tron F; Masmoudi H; Makni S;
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1073-8. PubMed ID: 19453789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
    Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
    Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
    Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
    Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins.
    Langenhan J; Dworschak J; Saschenbrecker S; Komorowski L; Schlumberger W; Stöcker W; Westermann J; Recke A; Zillikens D; Schmidt E; Probst C
    Exp Dermatol; 2014 Apr; 23(4):253-9. PubMed ID: 24533885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.